1. Home
  2. DOX vs PCVX Comparison

DOX vs PCVX Comparison

Compare DOX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amdocs Limited

DOX

Amdocs Limited

HOLD

Current Price

$62.37

Market Cap

6.9B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$53.66

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOX
PCVX
Founded
1982
2013
Country
United States
United States
Employees
N/A
507
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
7.8B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
DOX
PCVX
Price
$62.37
$53.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$92.33
$88.25
AVG Volume (30 Days)
848.0K
1.3M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
3.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
$13.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.40
$29.10
52 Week High
$94.32
$65.00

Technical Indicators

Market Signals
Indicator
DOX
PCVX
Relative Strength Index (RSI) 42.33 39.40
Support Level N/A $52.04
Resistance Level $67.82 $56.04
Average True Range (ATR) 1.73 2.56
MACD -0.30 -0.52
Stochastic Oscillator 44.37 41.35

Price Performance

Historical Comparison
DOX
PCVX

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: